HITI
NASDAQ · Pharmaceuticals
High Tide Inc
$2.70
-0.11 (-3.91%)
Open$2.77
Previous Close$2.81
Day High$2.81
Day Low$2.68
52W High$4.32
52W Low$2.86
Volume—
Avg Volume54.6K
Market Cap349.44M
P/E Ratio—
EPS$-0.52
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,337.4% upside
Current
$2.70
$2.70
Target
$38.81
$38.81
$30.55
$38.81 avg
$50.01
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 935.46M | 789.35M | 117.29M |
| Net Income | -79,918,007 | -60,692,098 | 15.94M |
| Profit Margin | -8.5% | -8.1% | 13.6% |
| EBITDA | 6.38M | 5.11M | 20.19M |
| Free Cash Flow | — | — | 10.06M |
| Rev Growth | +18.5% | +18.5% | +17.8% |
| Debt/Equity | 1.25 | 1.25 | 1.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |